I’ve written about the diabetes drug Avandia a dozen times already, but once again, this zombie drug has arisen from the near-dead to haunt the world of diabetes. This time it’s the FDA who breathed life into the drug, convening another Advisory Committee (AdCom) meeting earlier this month to review the manufacturer’s latest... Read more
Way back in 2009, three diabetes organizations (the American Diabetes Association (ADA), the International Diabetes Federation (IDF), and the European Association for the Study of Diabetes (EASD)) agreed that the A1C test (AKA “hemoglobin A1C” or "HbA1c" or A1c) was sufficient helpful that it could be used to establish a... Read more
In a recent commentary, Why People with Diabetes Need to Avoid Statins, David Mendosa makes his case against the use of statins for people with diabetes (PWD). He uses a newly-published study, “Simvastatin impairs exercise training adaptations” as his main argument. I also reviewed the preprint of the study, kindly supplied... Read more
Reviewing the diabetes news recently, I stumbled across three stories that the reader might be interested in knowing about. Or maybe not?
1) Although there’s a quarterback in the National Football League with type 1 diabetes (Jay Cutler), the New England Patriots released a defensive tackle (Kyle Love) who was apparently recently... Read more
Recently, the question was asked: “Does anyone have any tricks for knowing when it’s time to toss a vial of insulin?” The writer was concerned about whether a vial contains bad insulin – that is, insulin that has a diminished ability to decrease blood sugar levels compared to what was expected. There are lots of discussions... Read more
